Company Filing History:
1 out of 69 
1 out of 1,187 
Years Active: 2018
Title: Natalia De Val Alda: Innovator in HIV Research
Introduction: Natalia De Val Alda is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of HIV research, particularly in the development of novel vaccine candidates. Her work focuses on creating immunogenic compositions that can aid in the fight against HIV-1.
Latest Patents: Natalia holds a patent for "Soluble HIV-1 envelope glycoprotein trimers." This invention relates to innovative HIV-1 envelope glycoproteins that can be utilized as immunogens for vaccines, as well as antigens for crystallization and the identification of broad neutralizing antibodies. The patent encompasses the preparation and purification of these immunogenic compositions, which are crucial for formulating effective vaccines.
Career Highlights: Throughout her career, Natalia has worked with esteemed organizations such as the International Aids Vaccine Initiative and The Scripps Research Institute. Her dedication to advancing HIV research has positioned her as a key figure in the scientific community.
Collaborations: Natalia has collaborated with notable scientists, including Richard Wyatt and Andrew B. Ward. These partnerships have further enhanced her research and contributed to the development of innovative solutions in the fight against HIV.
Conclusion: Natalia De Val Alda's work exemplifies the impact of innovative research in the field of HIV. Her contributions through patents and collaborations continue to pave the way for advancements in vaccine development.